-
1
-
-
34447539951
-
Repeated hospitalizations predict mortality in the community population with heart failure
-
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154(2):260-266.
-
(2007)
Am Heart J.
, vol.154
, Issue.2
, pp. 260-266
-
-
Setoguchi, S.1
Stevenson, L.W.2
Schneeweiss, S.3
-
2
-
-
70349907873
-
The heart failure frequent flyer: An urban legend
-
Mills RM. The heart failure frequent flyer: An urban legend. Clin Cardiol. 2009;32(2):67-68.
-
(2009)
Clin Cardiol.
, vol.32
, Issue.2
, pp. 67-68
-
-
Mills, R.M.1
-
3
-
-
84941621522
-
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations
-
Nieminen MS, Dickstein K, Fonseca C, et al. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015;191:256-264.
-
(2015)
Int J Cardiol.
, vol.191
, pp. 256-264
-
-
Nieminen, M.S.1
Dickstein, K.2
Fonseca, C.3
-
4
-
-
84995363390
-
EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population
-
EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology
-
Nieminen MS, Brutsaert D, Dickstein K, et al; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27 (22):2725-2736.
-
(2006)
Eur Heart J.
, vol.27
, Issue.22
, pp. 2725-2736
-
-
Nieminen, M.S.1
Brutsaert, D.2
Dickstein, K.3
-
5
-
-
54049105749
-
Transition from chronic compensated to acute decompensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures
-
Zile MR, Bennett TD, St John Sutton M, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118(14): 1433-1441.
-
(2008)
Circulation
, vol.118
, Issue.14
, pp. 1433-1441
-
-
Zile, M.R.1
Bennett, T.D.2
St John Sutton, M.3
-
6
-
-
84864241198
-
Rehospitalization for heart failure: Predict or prevent?
-
Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012; 126(4):501-506.
-
(2012)
Circulation
, vol.126
, Issue.4
, pp. 501-506
-
-
Desai, A.S.1
Stevenson, L.W.2
-
7
-
-
79955132796
-
Proportion of hospital readmissions deemed avoidable: A systematic review
-
vanWalraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: A systematic review. CMAJ. 2011;183(7):E391-E402.
-
(2011)
CMAJ
, vol.183
, Issue.7
, pp. E391-E402
-
-
Van Walraven, C.1
Bennett, C.2
Jennings, A.3
Austin, P.C.4
Forster, A.J.5
-
8
-
-
85029584953
-
Hospital-readmission risk-isolating hospital effects from patient effects
-
Krumholz HM, Wang K, Lin Z, et al. Hospital-readmission risk-isolating hospital effects from patient effects. N Engl J Med. 2017;377(11): 1055-1064.
-
(2017)
N Engl J Med
, vol.377
, Issue.11
, pp. 1055-1064
-
-
Krumholz, H.M.1
Wang, K.2
Lin, Z.3
-
9
-
-
84925868796
-
Certain uncertainty: Life after stroke from the patient's perspective
-
Hannah D, Lindholm B, Maisch L. Certain uncertainty: life after stroke from the patient's perspective. Circ Cardiovasc Qual Outcomes. 2014;7 (6):968-969.
-
(2014)
Circ Cardiovasc Qual Outcomes
, vol.7
, Issue.6
, pp. 968-969
-
-
Hannah, D.1
Lindholm, B.2
Maisch, L.3
-
10
-
-
84959564096
-
Assessment of home-time after acute ischemic stroke in Medicare beneficiaries
-
Fonarow GC, Liang L, Thomas L, et al. Assessment of home-time after acute ischemic stroke in Medicare beneficiaries. Stroke. 2016;47 (3):836-842.
-
(2016)
Stroke
, vol.47
, Issue.3
, pp. 836-842
-
-
Fonarow, G.C.1
Liang, L.2
Thomas, L.3
-
11
-
-
84870540437
-
Patients with acute heart failure in the emergency department: Do they all need to be admitted?
-
Pang PS, Jesse R, Collins SP, Maisel A. Patients with acute heart failure in the emergency department: do they all need to be admitted? J Card Fail. 2012;18(12):900-903.
-
(2012)
J Card Fail
, vol.18
, Issue.12
, pp. 900-903
-
-
Pang, P.S.1
Jesse, R.2
Collins, S.P.3
Maisel, A.4
-
12
-
-
84871912144
-
Is hospital admission for heart failure really necessary? the role of the emergency department and observation unit in preventing hospitalization and rehospitalization
-
Collins SP, Pang PS, Fonarow GC, Yancy CW, Bonow RO, Gheorghiade M. Is hospital admission for heart failure really necessary? the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J AmColl Cardiol. 2013;61(2):121-126.
-
(2013)
J Am Coll Cardiol
, vol.61
, Issue.2
, pp. 121-126
-
-
Collins, S.P.1
Pang, P.S.2
Fonarow, G.C.3
Yancy, C.W.4
Bonow, R.O.5
Gheorghiade, M.6
-
13
-
-
85027501384
-
Hospitalization for recently diagnosed versus worsening chronic heart failure: From the ASCEND-HF trial
-
Greene SJ, Hernandez AF, Dunning A, et al. Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial. J AmColl Cardiol. 2017;69(25): 3029-3039.
-
(2017)
J Am Coll Cardiol
, vol.69
, Issue.25
, pp. 3029-3039
-
-
Greene, S.J.1
Hernandez, A.F.2
Dunning, A.3
-
14
-
-
84907303502
-
Recognizing worsening chronic heart failure as an entity and an end point in clinical trials
-
Butler J, Braunwald E, Gheorghiade M. Recognizing worsening chronic heart failure as an entity and an end point in clinical trials. JAMA. 2014; 312(8):789-790.
-
(2014)
JAMA
, vol.312
, Issue.8
, pp. 789-790
-
-
Butler, J.1
Braunwald, E.2
Gheorghiade, M.3
-
15
-
-
34748819364
-
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
-
Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators
-
Solomon SD, Dobson J, Pocock S, et al; Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116(13): 1482-1487.
-
(2007)
Circulation
, vol.116
, Issue.13
, pp. 1482-1487
-
-
Solomon, S.D.1
Dobson, J.2
Pocock, S.3
-
16
-
-
84871927704
-
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: Correlation with outcomes
-
RELAX-AHF Investigators
-
Metra M, Cotter G, Davison BA, et al; RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J AmColl Cardiol. 2013;61(2):196-206.
-
(2013)
J Am Coll Cardiol
, vol.61
, Issue.2
, pp. 196-206
-
-
Metra, M.1
Cotter, G.2
Davison, B.A.3
-
17
-
-
59749099461
-
Acute heart failure syndromes
-
Gheorghiade M, Pang PS. Acute heart failure syndromes. J AmColl Cardiol. 2009;53(7):557-573.
-
(2009)
J Am Coll Cardiol
, vol.53
, Issue.7
, pp. 557-573
-
-
Gheorghiade, M.1
Pang, P.S.2
-
18
-
-
84899472608
-
Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
-
Skali H, Dwyer EM, Goldstein R, et al. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT. Eur J Heart Fail. 2014;16 (5):560-565.
-
(2014)
Eur J Heart Fail
, vol.16
, Issue.5
, pp. 560-565
-
-
Skali, H.1
Dwyer, E.M.2
Goldstein, R.3
-
19
-
-
84964206619
-
Importance of clinical worsening of heart failure treated in the outpatient setting: Evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)
-
PARADIGM-HF Investigators and Committees
-
Okumura N, Jhund PS, Gong J, et al; PARADIGM-HF Investigators and Committees. Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Circulation. 2016;133(23):2254-2262.
-
(2016)
Circulation
, vol.133
, Issue.23
, pp. 2254-2262
-
-
Okumura, N.1
Jhund, P.S.2
Gong, J.3
-
20
-
-
84958830961
-
Temporal changes in postdischarge mortality risk after hospitalization for heart failure (from the EVEREST Trial)
-
Cook TD, Greene SJ, Kalogeropoulos AP, et al. Temporal changes in postdischarge mortality risk after hospitalization for heart failure (from the EVEREST Trial). Am J Cardiol. 2016;117(4):611-616.
-
(2016)
Am J Cardiol
, vol.117
, Issue.4
, pp. 611-616
-
-
Cook, T.D.1
Greene, S.J.2
Kalogeropoulos, A.P.3
-
21
-
-
84949537528
-
Serial high sensitivity cardiac troponin T measurement in acute heart failure: Insights from the RELAX-AHF study
-
Felker GM, Mentz RJ, Teerlink JR, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015;17(12):1262-1270.
-
(2015)
Eur J Heart Fail.
, vol.17
, Issue.12
, pp. 1262-1270
-
-
Felker, G.M.1
Mentz, R.J.2
Teerlink, J.R.3
-
22
-
-
85045900865
-
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: Findings from the ASTRONAUT trial
-
ASTRONAUT Investigators and Coordinators.[published online October 17, 2017
-
Greene SJ, Butler J, Fonarow GC, et al; ASTRONAUT Investigators and Coordinators. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial [published online October 17, 2017]. Eur J Heart Fail. 2017.
-
(2017)
Eur J Heart Fail
-
-
Greene, S.J.1
Butler, J.2
Fonarow, G.C.3
-
23
-
-
84878645318
-
Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients
-
Eapen ZJ, Liang L, Fonarow GC, et al. Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. JACC Heart Fail. 2013;1(3):245-251.
-
(2013)
JACC Heart Fail
, vol.1
, Issue.3
, pp. 245-251
-
-
Eapen, Z.J.1
Liang, L.2
Fonarow, G.C.3
-
24
-
-
84995938203
-
Analysis of machine learning techniques for heart failure readmissions
-
Mortazavi BJ, Downing NS, Bucholz EM, et al. Analysis of machine learning techniques for heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2016;9(6):629-640.
-
(2016)
Circ Cardiovasc Qual Outcomes
, vol.9
, Issue.6
, pp. 629-640
-
-
Mortazavi, B.J.1
Downing, N.S.2
Bucholz, E.M.3
-
25
-
-
85017203403
-
Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: Comparison of machine learning and other statistical approaches
-
Frizzell JD, Liang L, Schulte PJ, et al. Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: comparison of machine learning and other statistical approaches. JAMA Cardiol. 2017;2(2):204-209.
-
(2017)
JAMA Cardiol
, vol.2
, Issue.2
, pp. 204-209
-
-
Frizzell, J.D.1
Liang, L.2
Schulte, P.J.3
-
26
-
-
29344440492
-
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
-
ADHERE Scientific Advisory Committee and Investigators
-
Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J AmColl Cardiol. 2006;47(1):76-84.
-
(2006)
J AmColl Cardiol.
, vol.47
, Issue.1
, pp. 76-84
-
-
Yancy, C.W.1
Lopatin, M.2
Stevenson, L.W.3
De Marco, T.4
Fonarow, G.C.5
-
27
-
-
0016403662
-
Cardiac decompensation
-
Ramírez A, Abelmann WH. Cardiac decompensation. N Engl J Med. 1974;290(9): 499-501.
-
(1974)
N Engl J Med.
, vol.290
, Issue.9
, pp. 499-501
-
-
Ramírez, A.1
Abelmann, W.H.2
-
28
-
-
84884294190
-
2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines
-
Yancy CW, Jessup M, Bozkurt B, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2013;62(16):e147-e239.
-
(2013)
J Am Coll Cardiol
, vol.62
, Issue.16
, pp. e147-e239
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
-
29
-
-
14844291419
-
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
-
ADHERE Scientific Advisory Committee and Investigators
-
Adams KF Jr, Fonarow GC, Emerman CL, et al; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2): 209-216.
-
(2005)
Am Heart J.
, vol.149
, Issue.2
, pp. 209-216
-
-
Adams, K.F.1
Fonarow, G.C.2
Emerman, C.L.3
-
30
-
-
84896961871
-
The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries
-
Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J AmColl Cardiol. 2014;63(12):1123-1133.
-
(2014)
J Am Coll Cardiol
, vol.63
, Issue.12
, pp. 1123-1133
-
-
Ambrosy, A.P.1
Fonarow, G.C.2
Butler, J.3
-
31
-
-
77950485827
-
The impact of early standard therapy on dyspnoea in patients with acute heart failure: The URGENT-dyspnoea study
-
Mebazaa A, Pang PS, Tavares M, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: The URGENT-dyspnoea study. Eur Heart J. 2010;31(7): 832-841.
-
(2010)
Eur Heart J.
, vol.31
, Issue.7
, pp. 832-841
-
-
Mebazaa, A.1
Pang, P.S.2
Tavares, M.3
-
32
-
-
40649118759
-
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study
-
COMPASS-HF Study Group
-
Bourge RC, Abraham WT, Adamson PB, et al; COMPASS-HF Study Group. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study. J AmColl Cardiol. 2008;51(11): 1073-1079.
-
(2008)
J Am Coll Cardiol
, vol.51
, Issue.11
, pp. 1073-1079
-
-
Bourge, R.C.1
Abraham, W.T.2
Adamson, P.B.3
-
33
-
-
77950884226
-
Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study
-
PARTNERS Study Investigators
-
Whellan DJ, Ousdigian KT, Al-Khatib SM, et al; PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J AmColl Cardiol. 2010;55(17): 1803-1810.
-
(2010)
J Am Coll Cardiol
, vol.55
, Issue.17
, pp. 1803-1810
-
-
Whellan, D.J.1
Ousdigian, K.T.2
Al-Khatib, S.M.3
-
34
-
-
79951850287
-
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial
-
CHAMPION Trial Study Group
-
Abraham WT, Adamson PB, Bourge RC, et al; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet. 2011; 377(9766):658-666.
-
(2011)
Lancet
, vol.377
, Issue.9766
, pp. 658-666
-
-
Abraham, W.T.1
Adamson, P.B.2
Bourge, R.C.3
-
35
-
-
85019093819
-
Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in "real-world" clinical practice
-
Desai AS, Bhimaraj A, Bharmi R, et al. Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in "real-world" clinical practice. J AmColl Cardiol. 2017;69(19):2357-2365.
-
(2017)
J Am Coll Cardiol
, vol.69
, Issue.19
, pp. 2357-2365
-
-
Desai, A.S.1
Bhimaraj, A.2
Bharmi, R.3
-
36
-
-
84964766138
-
Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring
-
Costanzo MR, Stevenson LW, Adamson PB, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 2016;4 (5):333-344.
-
(2016)
JACC Heart Fail
, vol.4
, Issue.5
, pp. 333-344
-
-
Costanzo, M.R.1
Stevenson, L.W.2
Adamson, P.B.3
-
37
-
-
84964725582
-
Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure
-
Sandhu AT, Goldhaber-Fiebert JD, Owens DK, Turakhia MP, Kaiser DW, Heidenreich PA. Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. JACC Heart Fail. 2016;4(5):368-375.
-
(2016)
JACC Heart Fail.
, vol.4
, Issue.5
, pp. 368-375
-
-
Sandhu, A.T.1
Goldhaber-Fiebert, J.D.2
Owens, D.K.3
Turakhia, M.P.4
Kaiser, D.W.5
Heidenreich, P.A.6
-
38
-
-
85034670165
-
Postmarketing adverse events related to the CardioMEMS HF system
-
Vaduganathan M, DeFilippis EM, Fonarow GC, Butler J, Mehra MR. Postmarketing adverse events related to the CardioMEMS HF system. JAMA Cardiol. 2017;2(11):1277-1279.
-
(2017)
JAMA Cardiol
, vol.2
, Issue.11
, pp. 1277-1279
-
-
Vaduganathan, M.1
DeFilippis, E.M.2
Fonarow, G.C.3
Butler, J.4
Mehra, M.R.5
-
39
-
-
77955466458
-
Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)
-
Fonarow GC, Albert NM, Curtis AB, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122(6):585-596.
-
(2010)
Circulation
, vol.122
, Issue.6
, pp. 585-596
-
-
Fonarow, G.C.1
Albert, N.M.2
Curtis, A.B.3
-
40
-
-
85015670799
-
Acute heart failure: Alternatives to hospitalization
-
Zsilinszka R, Mentz RJ, DeVore AD, Eapen ZJ, Pang PS, Hernandez AF. Acute heart failure: Alternatives to hospitalization. JACC Heart Fail. 2017;5(5):329-336.
-
(2017)
JACC Heart Fail.
, vol.5
, Issue.5
, pp. 329-336
-
-
Zsilinszka, R.1
Mentz, R.J.2
DeVore, A.D.3
Eapen, Z.J.4
Pang, P.S.5
Hernandez, A.F.6
-
41
-
-
84938289631
-
Thinking outside the box: Treating acute heart failure outside the hospital to improve care and reduce admissions
-
DeVore AD, Allen LA, Eapen ZJ. Thinking outside the box: Treating acute heart failure outside the hospital to improve care and reduce admissions. J Card Fail. 2015;21(8):667-673.
-
(2015)
J Card Fail.
, vol.21
, Issue.8
, pp. 667-673
-
-
DeVore, A.D.1
Allen, L.A.2
Eapen, Z.J.3
-
42
-
-
84951779726
-
Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit
-
Buckley LF, Carter DM, Matta L, et al. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. JACC Heart Fail. 2016;4(1):1-8.
-
(2016)
JACC Heart Fail
, vol.4
, Issue.1
, pp. 1-8
-
-
Buckley, L.F.1
Carter, D.M.2
Matta, L.3
-
43
-
-
84928943057
-
The diuresis clinic: A new paradigm for the treatment of mild decompensated heart failure
-
Makadia S, Simmons T, Augustine S, et al. The diuresis clinic: A new paradigm for the treatment of mild decompensated heart failure. Am J Med. 2015;128(5):527-531.
-
(2015)
Am J Med.
, vol.128
, Issue.5
, pp. 527-531
-
-
Makadia, S.1
Simmons, T.2
Augustine, S.3
-
44
-
-
81955168095
-
Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program
-
Hebert K, Dias A, Franco E, Tamariz L, Steen D, Arcement LM. Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program. Congest Heart Fail. 2011;17(6):309-313.
-
(2011)
Congest Heart Fail.
, vol.17
, Issue.6
, pp. 309-313
-
-
Hebert, K.1
Dias, A.2
Franco, E.3
Tamariz, L.4
Steen, D.5
Arcement, L.M.6
-
45
-
-
0037181515
-
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial
-
Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators
-
Cuffe MS, Califf RM, Adams KF Jr, et al; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA. 2002;287(12):1541-1547.
-
(2002)
JAMA
, vol.287
, Issue.12
, pp. 1541-1547
-
-
Cuffe, M.S.1
Califf, R.M.2
Adams, K.F.3
-
46
-
-
35848944656
-
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials
-
VERITAS Investigators
-
McMurray JJ, Teerlink JR, Cotter G, et al; VERITAS Investigators. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials. JAMA. 2007;298(17):2009-2019.
-
(2007)
JAMA
, vol.298
, Issue.17
, pp. 2009-2019
-
-
McMurray, J.J.1
Teerlink, J.R.2
Cotter, G.3
-
47
-
-
77957730950
-
PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
Massie BM, O'Connor CM, Metra M, et al; PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010;363(15): 1419-1428.
-
(2010)
N Engl J Med.
, vol.363
, Issue.15
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
-
48
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011; 365(1):32-43.
-
(2011)
N Engl J Med
, vol.365
, Issue.1
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
-
49
-
-
84877960102
-
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure
-
REVIVE Heart Failure Study Group
-
Packer M, Colucci W, Fisher L, et al; REVIVE Heart Failure Study Group. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013;1(2):103-111.
-
(2013)
JACC Heart Fail.
, vol.1
, Issue.2
, pp. 103-111
-
-
Packer, M.1
Colucci, W.2
Fisher, L.3
-
50
-
-
84871986523
-
Relaxin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial
-
Teerlink JR, Cotter G, Davison BA, et al; Relaxin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial. Lancet. 2013;381(9860):29-39.
-
(2013)
Lancet
, vol.381
, Issue.9860
, pp. 29-39
-
-
Teerlink, J.R.1
Cotter, G.2
Davison, B.A.3
-
51
-
-
85003914653
-
Rationale for and design of the TRUE-AHF trial: The effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure
-
TRUE-AHF Investigators and Committees
-
Packer M, Holcomb R, AbrahamWT, et al; TRUE-AHF Investigators and Committees. Rationale for and design of the TRUE-AHF trial: The effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. Eur J Heart Fail. 2017;19(5):673-681.
-
(2017)
Eur J Heart Fail
, vol.19
, Issue.5
, pp. 673-681
-
-
Packer, M.1
Holcomb, R.2
Abraham, W.T.3
-
52
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
-
Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
-
Konstam MA, Gheorghiade M, Burnett JC Jr, et al; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA. 2007;297(12): 1319-1331.
-
(2007)
JAMA
, vol.297
, Issue.12
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, J.C.3
-
53
-
-
84875176312
-
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial
-
ASTRONAUT Investigators and Coordinators
-
Gheorghiade M, Böhm M, Greene SJ, et al; ASTRONAUT Investigators and Coordinators. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial. JAMA. 2013;309(11):1125-1135.
-
(2013)
JAMA
, vol.309
, Issue.11
, pp. 1125-1135
-
-
Gheorghiade, M.1
Böhm, M.2
Greene, S.J.3
-
54
-
-
84949489402
-
Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-REDUCED randomized trial
-
SOCRATES-REDUCED Investigators and Coordinators
-
Gheorghiade M, Greene SJ, Butler J, et al; SOCRATES-REDUCED Investigators and Coordinators. Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-REDUCED randomized trial. JAMA. 2015;314(21):2251-2262.
-
(2015)
JAMA
, vol.314
, Issue.21
, pp. 2251-2262
-
-
Gheorghiade, M.1
Greene, S.J.2
Butler, J.3
-
55
-
-
85019456074
-
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: Results of the Soluble Guanylate Cyclase Stimulator in Heart Failure Patients with PRESERVED EF (SOCRATES-PRESERVED) study
-
Pieske B, Maggioni AP, Lam CSP, et al. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the Soluble Guanylate Cyclase Stimulator in Heart Failure Patients with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J. 2017; 38(15):1119-1127.
-
(2017)
Eur Heart J.
, vol.38
, Issue.15
, pp. 1119-1127
-
-
Pieske, B.1
Maggioni, A.P.2
Lam, C.S.P.3
-
56
-
-
84901003001
-
Diuretic response in acute heart failure: Clinical characteristics and prognostic significance
-
Valente MAE, Voors AA, Damman K, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35(19):1284-1293.
-
(2014)
Eur Heart J.
, vol.35
, Issue.19
, pp. 1284-1293
-
-
Valente, M.A.E.1
Voors, A.A.2
Damman, K.3
-
57
-
-
84916618655
-
Diuretic response in patients with acute decompensated heart failure: Characteristics and clinical outcome-an analysis from RELAX-AHF
-
RELAX-AHF Investigators
-
Voors AA, Davison BA, Teerlink JR, et al; RELAX-AHF Investigators. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF. Eur J Heart Fail. 2014;16(11): 1230-1240.
-
(2014)
Eur J Heart Fail
, vol.16
, Issue.11
, pp. 1230-1240
-
-
Voors, A.A.1
Davison, B.A.2
Teerlink, J.R.3
-
58
-
-
84939568411
-
Diuretic response in acute heart failure-an analysis from ASCEND-HF
-
ter Maaten JM, Dunning AM, Valente MA, et al. Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J. 2015;170(2):313-321.
-
(2015)
Am Heart J
, vol.170
, Issue.2
, pp. 313-321
-
-
Ter Maaten, J.M.1
Dunning, A.M.2
Valente, M.A.3
-
59
-
-
0021969464
-
Furosemide absorption altered in decompensated congestive heart failure
-
Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med. 1985;102(3):314-318.
-
(1985)
Ann Intern Med.
, vol.102
, Issue.3
, pp. 314-318
-
-
Vasko, M.R.1
Cartwright, D.B.2
Knochel, J.P.3
Nixon, J.V.4
Brater, D.C.5
-
60
-
-
1642568269
-
Diuretic effects of subcutaneous furosemide in human volunteers: A randomized pilot study
-
Verma AK, da Silva JH, Kuhl DR. Diuretic effects of subcutaneous furosemide in human volunteers: A randomized pilot study. Ann Pharmacother. 2004;38(4):544-549.
-
(2004)
Ann Pharmacother
, vol.38
, Issue.4
, pp. 544-549
-
-
Verma, A.K.1
Da Silva, J.H.2
Kuhl, D.R.3
-
61
-
-
80051959101
-
Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?
-
Zacharias H, Raw J, Nunn A, Parsons S, Johnson M. Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure? Palliat Med. 2011;25(6):658-663.
-
(2011)
Palliat Med.
, vol.25
, Issue.6
, pp. 658-663
-
-
Zacharias, H.1
Raw, J.2
Nunn, A.3
Parsons, S.4
Johnson, M.5
-
62
-
-
85039930352
-
Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure
-
published online November 27, 2017
-
Gilotra NA, Princewill O, Okwuosa IS, et al. Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure [published online November 27, 2017]. JACC Heart Fail. doi:10.1016/j.jchf.2017.10.001.
-
JACC Heart Fail.
-
-
Gilotra, N.A.1
Princewill, O.2
Okwuosa, I.S.3
-
63
-
-
85019818217
-
Effect of ularitide on cardiovascular mortality in acute heart failure
-
TRUE-AHF Investigators
-
Packer M, O'Connor C, McMurray JJV, et al; TRUE-AHF Investigators. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med. 2017;376(20):1956-1964.
-
(2017)
N Engl J Med
, vol.376
, Issue.20
, pp. 1956-1964
-
-
Packer, M.1
O'Connor, C.2
McMurray, J.J.V.3
-
64
-
-
0034721244
-
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
-
Nesiritide Study Group
-
Colucci WS, Elkayam U, Horton DP, et al; Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343(4):246-253.
-
(2000)
N Engl J Med.
, vol.343
, Issue.4
, pp. 246-253
-
-
Colucci, W.S.1
Elkayam, U.2
Horton, D.P.3
-
65
-
-
79551561121
-
Novel natriuretic peptides: New compounds and new approaches
-
Vogel MW, Chen HH. Novel natriuretic peptides: new compounds and new approaches. Curr Heart Fail Rep. 2011;8(1):22-27.
-
(2011)
Curr Heart Fail Rep.
, vol.8
, Issue.1
, pp. 22-27
-
-
Vogel, M.W.1
Chen, H.H.2
-
66
-
-
84956611096
-
Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure
-
McKie PM, Schirger JA, Benike SL, et al. Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure. Eur J Heart Fail. 2016;18(4):433-441.
-
(2016)
Eur J Heart Fail.
, vol.18
, Issue.4
, pp. 433-441
-
-
McKie, P.M.1
Schirger, J.A.2
Benike, S.L.3
-
67
-
-
84870239189
-
Novel protein therapeutics for systolic heart failure: Chronic subcutaneous B-type natriuretic peptide
-
Chen HH, Glockner JF, Schirger JA, Cataliotti A, Redfield MM, Burnett JC Jr. Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide. J AmColl Cardiol. 2012;60(22):2305-2312.
-
(2012)
J AmColl Cardiol.
, vol.60
, Issue.22
, pp. 2305-2312
-
-
Chen, H.H.1
Glockner, J.F.2
Schirger, J.A.3
Cataliotti, A.4
Redfield, M.M.5
Burnett, J.C.6
|